China and the US have a long history of cooperation on opioid control. The latest announcement is pure White House theatre.
China and the US have a long history of cooperation on opioid control. The latest announcement is pure White House theatre.
This week at the G20 summit, President Trump announced that China had agreed that the export of synthetic opioids, namely Fentanyls, to the US would be curtailed. John Collinswrites that the move is another political ‘sugar rush’ for the administration which is unlikely to address the US opioid crisis. Delving into the long history of US-China cooperation on drug policy, he finds that this latest announcement is yet another example of an unfocused measure aimed at reducing the flow of drugs into the US from China, and ignores and distracts from the needs of a more effective domestic response to the overdose crisis. (LSE – London School of Economics, US Centre, Dezember 2018)